Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient

Mol Genet Metab. 2007 Apr;90(4):453-7. doi: 10.1016/j.ymgme.2006.12.010. Epub 2007 Feb 1.

Abstract

Abetalipoproteinemia (ABL) is a rare autosomal recessive metabolic disorder, characterized by the absence of plasma apolipoprotein B-containing lipoproteins and very low levels of plasma triglycerides and cholesterol. ABL is caused by mutations of the MTP gene. We investigated the genetic basis for ABL in a cohort of Israeli families. In Ashkenazi Jewish patients we identified a conserved haplotype and a common MTP mutation, p.G865X, with a carrier frequency of 1:131 in this population. We also report the first case of ABL and additional abnormalities in a Muslim Arab patient, due to a homozygous contiguous gene deletion of approximately 481 kb, including MTP and eight other genes.

MeSH terms

  • Abetalipoproteinemia / genetics*
  • Apolipoproteins B / blood
  • Apolipoproteins B / deficiency
  • Arabs
  • Cholesterol / blood
  • Cholesterol / deficiency
  • Genetic Predisposition to Disease*
  • Haplotypes*
  • Humans
  • Israel
  • Jews
  • Mutation*
  • Population Groups*
  • Triglycerides / blood
  • Triglycerides / deficiency

Substances

  • Apolipoproteins B
  • Triglycerides
  • Cholesterol